Corporate revenues up, profitability deteriorates

Korea’s pharmaceutical companies saw their revenues jump on growing demand last year.

But their ability to generate cash from a variety of operating activities fell on worsening profitability as a result of the tough regulations and intense competition at home.

According to Yakup Shinmoon, the combined revenue of 107 firms rose 12 percent to 11.32 trillion won last year.

But their pro...